Nick Robinson, Senior Investment Manager, Equities
Emerging markets (EMs) are not immune to coronavirus-induced global market shocks.
When COVID-19 (coronavirus) first made headlines, in China, then worldwide, global market reactions were complacent. It was perceived as a primarily Chinese issue, reminiscent of the SARS outbreak of the early 2000s. Expectations were for a brief selloff, which would last only until the number of new cases retreated.
However, the virus has spread far beyond Chinese borders and erupted into a global pandemic. Global economic expectations changed dramatically in early March, and have continued to evolve just about daily since. Global growth forecasts for this year are likely to reach 40-year lows.
It’s uncertain what lies ahead, but COVID-19 is sure to dominate headlines in the near term, and it presents two big issues for markets.
The first is on the demand side. As a result of the sudden decline in economic activity, many companies will experience unprecedented declines in revenue. It is unlikely that many companies will be able to adjust cost bases quickly enough to this decline, so we are likely to see increased pressure on balance sheets and cashflows. This is likely to be an acute problem for small- and medium-sized businesses. These enterprises tend to have less-diverse revenue streams, are more consumption driven, and have less access to financing.
The second issue markets are facing is liquidity. These concerns manifest in two ways: market liquidity and company liquidity. The former is an issue because as markets fall, financial conditions tighten. This, in turn, drives markets even lower. The latter is problematic because as companies’ cash flows fall, the probability of credit defaults increase, which could threaten the economy at large. If companies go bankrupt, there will be labor shedding and people leaving the workforce, which would be a greater structural threat to the economy than just the current demand for liquidity.
These issues play out in an environment where oil markets are reeling after having received a dual shock. There has been a decline in demand due to the rapid slowdown in economic activity. There has also been a supply-side shock, driven by a price war between Saudi Arabia and Russia. Lower oil prices help consumers, but disrupt the supply chain and investment, which will have economic consequences that could be compounded by the coronavirus situation.
Government action will serve as the nuts and bolts for building a barricade against these more serious structural issues.
Thus far, central banks have responded by lowering rates and pumping liquidity into markets. Whilst this is an important step, we are still awaiting more fiscal-policy action, which may inspire enough confidence to stabilize markets. However, a lasting recovery will also depend on confidence that the rate of spread of the virus has been contained.
We may not be able to divine the full future economic effects of COVID-19, but we can look to history as a guide. In China, as a result of containment measures against the virus, industrial production experienced its steepest decline ever (even compared to the global financial crisis). This suggests that economic data around the world will continue to be grim – for now, at least. If we look further back, however, it’s clear that profit down cycles tend to be short and sharp vs. up cycles, in both EMs and the U.S (Chart 1).
Chart 1: Historic profit down cycles are shorter than upcycles
Source: Bloomberg March 2020. S&P 500 Unmanaged Index considered representative of the U.S. stock market. MSCI Emerging Markets Index is an unmanaged index considered representative of stocks of developing countries. The index is computed using the net return, which withholds applicable taxes for non‐resident investors.
The more governments are able to prevent demand-side problems and liquidity concerns from evolving into structural issues, the better the chance for a strong earnings recovery. All of this also hinges on how quickly coronavirus cases peak. Right now, it’s unclear as to whether the pandemic will continue in waves over a prolonged time, or be stemmed by summer 2020. In Hubei, the Chinese province where the virus originated, cases peaked in early March, about 6 weeks after the initial surge. While this may offer some guidance, the Chinese government has farther-reaching powers than many other states, which enabled them to quickly enact extremely strict containment measures. We expect that other nations will require longer lockdown periods because they cannot be as stringent. Because recovery depends on containment, we believe economies will experience a U-shaped recovery once measures are relaxed.
In emerging markets, the call for liquidity is being answered, which is promising. Additionally, emerging market balance sheets entered this crisis period in a healthy state, which may bode well for recovery. Reform agendas, especially in Brazil, also offer encouragement.
While this market rout appears, in many ways, similar to 2008, volatility may present an opportunity for long-term investors to initiate positions in high-quality companies with good valuations that can benefit from these market conditions.
IMPORTANT INFORMATION
The MSCI information may only be used for your internal use, may not be reproduced or redisseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis, should not be taken as an indication or guarantee of any future performance analysis forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI” Parties) expressly disclaims all warranties (including without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages (www.msci.com).
The views and conclusions expressed in this communication are for general interest only and should not be taken as investment advice or as an invitation to purchase or sell any specific security.
Any data contained herein which is attributed to a third party ("Third Party Data") is the property of (a) third party supplier(s) (the "Owner") and is licensed for use by Standard Life Aberdeen**. Third Party Data may not be copied or distributed. Third Party Data is provided "as is" and is not warranted to be accurate, complete or timely.
To the extent permitted by applicable law, none of the Owner, Standard Life Aberdeen** or any other third party (including any third party involved in providing and/or compiling Third Party Data) shall have any liability for Third Party Data or for any use made of Third Party Data. Past performance is no guarantee of future results. Neither the Owner nor any other third party sponsors, endorses or promotes the fund or product to which Third Party Data relates.
**Standard Life Aberdeen means the relevant member of Standard Life Aberdeen group, being Standard Life Aberdeen plc together with its subsidiaries, subsidiary undertakings and associated companies (whether direct or indirect) from time to time.
